Wand Martin

Hong Bryan Kun, Winer Jeffrey C, Martone James F, Wand Martin, Altman Bruce, Shields Bruce

This study found repeat 360-degree SLT can be safe and effective for glaucoma patients whose initial SLT treatment failed, providing a viable retreatment option.

George Mathew K, Emerson John W, Cheema Sameer A, McGlynn Robert, Ford Bryce A, Martone James F et al.

This study found that modified SLT with overlapping spots resulted in significantly worse IOP reduction than standard non-overlapping SLT or ALT, indicating standard protocols are more effective.

Reistad Chet E, Shields M Bruce, Campbell David G, Ritch Robert, Wang Jim C, Wand Martin

This study found laser peripheral iridotomy doesn't significantly improve long-term IOP control in pigmentary glaucoma when baseline differences are accounted for, suggesting LPI's benefit is unproven.

Pasternack James J, Wand Martin, Shields M Bruce, Abraham Deepa

This study found a combined ab-externo/ab-interno needle revision with 5-FU effectively restored failed glaucoma blebs, achieving high success in lowering IOP and medication use, offering a valuable treatment option.

Herndon Leon W, Robert D Williams, Wand Martin, Asrani Sanjay

Topical glaucoma lipids (latanoprost/bimatoprost) can cause periocular pigmentation and eyelash growth in African Americans, a reversible side effect clinicians should monitor for.

Day Douglas G, Schacknow Paul N, Wand Martin, Sharpe Elizabeth D, Stewart Jeanette A, Leech Jessica et al.

This study found timolol/dorzolamide fixed combination and timolol + unoprostone offer similar efficacy and safety for glaucoma/ocular hypertension, providing comparable IOP reduction throughout the day.

Wand Martin, Gaudio Alexander R

Ocular hypotensive lipids (unoprostone, travaprost, bimatoprost) caused cystoid macular edema in high-risk glaucoma patients, resolving with drug discontinuation and steroids. Caution is advised in similar cases.

Wand Martin, Shields Bruce M

This review found that while ocular hypotensive lipids can cause cystoid macular edema, the risk, even in high-risk eyes, is low, making them a viable alternative to surgery.